+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Live Attenuated Vaccine"

Novel Vaccine Delivery Devices Market, 2019-2030 - Product Thumbnail Image

Novel Vaccine Delivery Devices Market, 2019-2030

  • Report
  • November 2019
  • 403 Pages
  • Global
From
Nasal Vaccines: Global Markets and Pipeline Analysis - Product Thumbnail Image

Nasal Vaccines: Global Markets and Pipeline Analysis

  • Report
  • December 2022
  • 78 Pages
  • Global
From
Pediatric Vaccines: Global Markets - Product Thumbnail Image

Pediatric Vaccines: Global Markets

  • Report
  • September 2022
  • 110 Pages
  • Global
From
Influenza Vaccines: Global Markets - Product Thumbnail Image

Influenza Vaccines: Global Markets

  • Report
  • May 2022
  • 109 Pages
  • Global
From
From
From
Vaccines Global Market Opportunities And Strategies To 2031 - Product Thumbnail Image

Vaccines Global Market Opportunities And Strategies To 2031

  • Report
  • January 2023
  • 343 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus. Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines. Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more